Found "AI": 1,034 results
Pfizer to return rights to three Acura products
The license termination, which concerns three clinical-stage products using Acura’s Aversion technology, will be effective a year from Thursday, when Pfizer notified the company.“We will evaluate our strategy for these products (being returned) over the coming months, including possible partnering w
Pfizer settles foreign bribery case with U.S. government
The settlement is part of a broad crackdown on bribery by multinational companies in foreign countries that has hit several of the world’s biggest pharmaceutical companies.Pfizer in 2004 became the first pharmaceutical company to volunteer information about past wrongdoing to the Justice Department,
Peregrine drug doubles lung cancer survival in trial
Investors cheered the news, sending shares of the drugmaker soaring 50 percent to $4.59 on the Nasdaq on Friday afternoon.The Phase 2 trial, involving 121 previously treated non-small cell lung cancer patients, found that those given a lower dose of bavituximab plus chemotherapy lived for a median o
Perceived barriers to utilise methadone maintenance therapy among male injection drug users in rural areas of southern Thailand (2015)
ROONGNAPA KHAMPANG1,2, SAWITRI ASSANANGKORNCHAI1 & YOT TEERAWATTANANON2
1Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, HatYai, Songkhla, Thailand, and 2Health Intervention and Technology Assessment Program, Department of Health, Ministry of Public Health, Nonthaburi, Tha
Pay-for-performance in resource-constrained settings: Lessons learned from Thailand’s Quality and Outcomes Framework (2016)
Abstract
Introduction.
Many countries have introduced pay-for-performance (P4P) models to encourage health providers and institutions to provide good quality of care. In 2013, the National Health Security Office of Thailand introduced P4P, based on the UK Quality and Outcomes Framework (QOF),
Participation at the HTA Workshop in Manila, Philippines (7-9, Jan 2020)
Senegalese delegation with Dr. Yot Teerawattananon, Dr. Wanrudee Isaranuwatchai and Aparna Ananthakrishnan from HITAP
We are very honored to have participated in the Health Technology Assessment (HTA) training and symposium.We have seen interestin
Painkillers ‘are the cause’ of millions of headaches
Up to a million people in the UK have “completely preventable” severe headaches caused by taking too many painkillers, doctors have said.They said some were trapped in a “vicious cycle” of taking pain relief, which then caused even more headaches.The warning came as part of the National Institute fo
Package of Essential Non-communicable Disease Interventions Economic Evaluation (PEN EE)
In response to the request from Indonesia’s Ministry of Health (MOH), World Health Organization, South East Asia Regional Office (WHO SEARO) commissioned the HITAP International Unit (HIU) to provide support for the Package of Essential Non-communicable (PEN) disease intervention evaluation. The evaluation is predicted to include qualitative anal
OxyContin abuse down with time-release formula
(Reuters Health) – There’s more evidence that the new formulation of OxyContin, the time-release version of oxycodone, is discouraging abuse of the powerful drug.But the reformulation, introduced in August 2010 to make it harder to crush the medicine into powder, limiting the ability to snort, injec
10 / Page